Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-20-042771)

Filing Details

Accession Number:: 0001213900-20-042771
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-12-15 16:05:29
Reporting Period:: 2020-12-11

Accepted Time:: 2020-12-15 16:05:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1733413	Tff Pharmaceuticals Inc.	TFFP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1240140	S Robert Mills	2600 Via Fortuna, Suite 360 Austin TX 78746		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-12-11	22,794	$2.50	38,774	No	4	M	Direct
Common Stock	Disposition	2020-12-11	22,794	$14.58	15,980	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2020-12-11	22,794	$0.00	22,794	$2.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
219,719	2019-04-06	2028-04-06	No	4	M	Direct

Footnotes

The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options.
40,000 shares of the option vested and became exercisable on April 6, 2019.